Trazodone Food & Supplement Interactions: What to Eat, Avoid, and Watch

How Trazodone Works: The Mechanism Behind Its Interactions

Trazodone's interaction profile is shaped almost entirely by its mechanism of action. It blocks 5-HT2A and 5-HT2C serotonin receptors as an antagonist, simultaneously inhibits the serotonin transporter (SERT), and blocks histamine H1 and alpha-1 adrenergic receptors. Each of those four targets explains a specific category of interaction risk.

Serotonergic Activity and SERT Inhibition

By partially inhibiting SERT, trazodone increases synaptic serotonin. That same mechanism means anything else that raises serotonin levels adds to trazodone's serotoninergic load. The FDA's label for trazodone hydrochloride explicitly warns that combining it with other serotonergic agents can produce serotonin syndrome, a potentially life-threatening condition characterized by agitation, hyperthermia, clonus, and autonomic instability. [1]

The serotonin syndrome risk is not theoretical. A 2019 systematic review published in CNS Drugs identified serotonin-modulating supplements, particularly St. John's Wort and high-dose tryptophan, as underappreciated precipitants of serotonin toxicity when combined with prescription serotonergic agents. [2]

Alpha-1 Blockade and the Blood Pressure Connection

Trazodone's alpha-1 adrenergic antagonism lowers blood pressure, especially orthostatic blood pressure. Alcohol causes peripheral vasodilation through a different mechanism. When combined, the two agents produce additive drops in blood pressure that can cause dizziness and falls. This matters especially for older adults, who already face elevated orthostatic hypotension risk.

CYP3A4 Metabolism and Food-Drug Interactions

Trazodone is metabolized primarily by CYP3A4, with minor contributions from CYP2D6. [3] Any food or supplement that inhibits CYP3A4 will slow trazodone clearance, raising plasma concentrations and amplifying both therapeutic and adverse effects. Grapefruit is the most clinically significant dietary CYP3A4 inhibitor.

Histamine Blockade and Sedation Stacking

Trazodone's H1 antagonism drives much of its sedative effect at lower doses. Anything else with antihistamine or CNS depressant properties, including diphenhydramine-containing sleep aids, valerian root, and kava, will stack sedation unpredictably.

Taking Trazodone With Food: What the Evidence Says

Take trazodone with a light snack or small meal. This is not a blanket instruction to eat a full dinner. A 2011 pharmacokinetic study published in the Journal of Clinical Pharmacology confirmed that food increases trazodone's Cmax and AUC by roughly 20% and delays Tmax by approximately one hour, slowing absorption in a way that reduces nausea without meaningfully altering overall bioavailability. [4]

Why the Meal Size Matters

A large, high-fat meal prolongs the absorption window more than a light snack does. For depression dosing, where plasma level stability across the day matters, erratic meal patterns can produce variable drug levels. For bedtime insomnia dosing, a small snack roughly 30 minutes before the dose is the most common clinical recommendation because it limits nausea while still permitting relatively prompt onset of sedation.

Foods That Change Trazodone Levels

Grapefruit and grapefruit juice. Grapefruit contains furanocoumarins, particularly 6',7'-dihydroxybergamottin, that irreversibly inhibit intestinal CYP3A4. A single 8-ounce glass of grapefruit juice can suppress CYP3A4 activity for up to 72 hours. [5] Because trazodone depends heavily on CYP3A4 for first-pass metabolism, even one glass of grapefruit juice could raise trazodone plasma levels enough to worsen sedation, orthostatic hypotension, and QT-interval effects. Seville orange juice (used in some marmalades) carries a similar risk.

High-tyramine foods. Unlike MAOIs, trazodone does not inhibit monoamine oxidase. Aged cheeses, cured meats, and fermented foods pose no direct pharmacokinetic problem with trazodone. Patients switching from an MAOI to trazodone should confirm a 14-day washout period has elapsed, but the tyramine restriction itself does not apply to trazodone therapy.

Grapefruit is the one dietary item that warrants a complete stop. Everything else is a matter of dose timing or additive effect management.

Alcohol and Trazodone: A Clinically Significant Combination

Alcohol and trazodone should not be combined. The interaction is pharmacodynamic, not pharmacokinetic. Alcohol potentiates CNS depression through GABA-A receptor modulation, and trazodone adds sedation via H1 blockade and alpha-1 antagonism. [6]

What Happens in Practice

Clinical reports and case series document that even one to two standard drinks with a 100 mg trazodone dose can produce:

• Excessive sedation and next-day cognitive impairment
• Orthostatic hypotension with falls
• Respiratory depression risk in patients with sleep apnea

The American Academy of Sleep Medicine's 2017 clinical practice guideline on chronic insomnia treatment does not endorse alcohol as a sleep aid, specifically citing synergistic CNS depression when combined with sedating medications. [7]

Special Consideration for Older Adults

Adults over 65 are disproportionately prescribed trazodone for insomnia, and they are also more likely to consume alcohol socially. The Beers Criteria (2023 update) identifies CNS depressant combinations, including sedating antidepressants co-used with alcohol, as a major fall and fracture risk. [8] Physicians prescribing trazodone to older patients should document alcohol use and reinforce the avoidance message explicitly.

St. John's Wort and Trazodone: The Serotonin Syndrome Risk

St. John's Wort (Hypericum perforatum) inhibits SERT, NET, and DAT while also inducing CYP3A4. With trazodone, it creates a double problem: it raises synaptic serotonin by a different mechanism at the same time as trazodone, increasing serotonin syndrome risk, while simultaneously inducing CYP3A4 and potentially accelerating trazodone clearance. [9]

The net outcome is unpredictable. At lower St. John's Wort doses, serotonin syndrome risk may dominate. At higher doses or chronic use, CYP3A4 induction may reduce trazodone efficacy. Neither outcome is desirable.

The FDA issued a public health advisory specifically about St. John's Wort interactions with serotonergic drugs. [10] Patients who self-prescribe St. John's Wort for low mood and are also taking trazodone should be considered at risk and should discontinue one agent under medical supervision.

Serotonin syndrome warning signs to report immediately: agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle twitching, diarrhea, or fever.

Melatonin and Trazodone: Lower Risk, But Not Zero

Melatonin is the supplement question clinicians hear most often from trazodone patients. The short answer: melatonin does not directly interact with trazodone's metabolic pathways or serotonin receptors at standard doses (0.5 to 5 mg). [11]

Where the Concern Comes From

Trazodone blocks 5-HT2A receptors, which are involved in circadian rhythm modulation. Melatonin acts on MT1 and MT2 receptors in the suprachiasmatic nucleus. These are distinct receptor populations. There is no established pharmacodynamic interaction between melatonin and trazodone that would cause serotonin toxicity.

The residual concern is simple additive sedation. Two agents that both support sleep onset may produce deeper or longer sedation than intended, with a risk of next-morning grogginess. For most adults taking 50 to 100 mg of trazodone, adding 0.5 to 1 mg of melatonin is unlikely to produce problematic sedation. Adding 10 mg of melatonin on top of 150 mg of trazodone is a different picture.

If a patient is already sleeping adequately on trazodone, melatonin typically adds little benefit and is unnecessary.

Tryptophan and 5-HTP Supplements: A Direct Serotonin Load

L-tryptophan and 5-hydroxytryptophan (5-HTP) are sold as sleep and mood supplements. Both are direct serotonin precursors. Tryptophan converts to 5-HTP via tryptophan hydroxylase, and 5-HTP converts to serotonin via aromatic amino acid decarboxylase. Taking either supplement with trazodone increases the substrate available for serotonin synthesis at the same time trazodone is inhibiting serotonin reuptake. [12]

Case reports link 5-HTP co-administration with SSRIs and SNRIs to serotonin syndrome. While published case reports specifically pairing 5-HTP with trazodone are limited, the pharmacology is identical in principle. The FDA's 1989 recall of contaminated L-tryptophan products did not remove the underlying mechanism concern, which persists for any quality of tryptophan supplement.

Clinical guidance: Patients using 5-HTP or L-tryptophan for sleep should discontinue those supplements before starting trazodone. If they decline, prescribers should document the discussion, lower the starting trazodone dose, and review symptoms at the two-week mark.

Kava, Valerian, and Other Sedating Herbals

Kava

Kava (Piper methysticum) produces sedation and anxiolysis through GABA-A modulation and sodium channel blockade. It also inhibits several CYP enzymes, including CYP3A4 and CYP2C9. [13] Combined with trazodone, kava may slow trazodone metabolism (raising plasma levels) while stacking sedative effects. The FDA issued a consumer advisory in 2002 warning about kava-associated hepatotoxicity; that liver risk is separate from but compounds the concern about combining kava with any hepatically metabolized drug.

Valerian Root

Valerian (Valeriana officinalis) modulates GABA-A receptors and may weakly inhibit GABA transaminase. It does not raise serotonin directly, so the serotonin syndrome concern is minimal. The interaction is purely additive sedation. For a patient taking 100 mg of trazodone at bedtime, adding a standard valerian dose (300 to 600 mg) may produce morning sedation that impairs driving. [14]

Lavender Oil (Silexan)

Silexan, an oral lavender oil preparation marketed as Silexan (80 mg), is approved in Germany for anxiety and has been studied in several placebo-controlled trials. Its anxiolytic mechanism involves VDAC-1 inhibition and serotonin reuptake inhibition at higher concentrations. The serotonin reuptake activity is weak, but in combination with trazodone it represents an additive serotonergic load that has not been formally studied. Caution is reasonable.

Magnesium, Omega-3s, and B-Vitamins: Generally Compatible

Several supplements commonly taken alongside antidepressants carry minimal interaction risk with trazodone.

Magnesium glycinate or magnesium threonate (200 to 400 mg) have no known CYP interactions and no direct serotonergic activity. They are frequently used for sleep quality and are compatible with trazodone.

Omega-3 fatty acids (EPA/DHA) at doses up to 3 to 4 g per day do not inhibit CYP3A4 in clinically meaningful ways. A meta-analysis published in Translational Psychiatry (2019, N=1,203 across 26 RCTs) found omega-3 supplementation produced a small but statistically significant antidepressant effect, which may be additive with trazodone's antidepressant activity rather than harmful. [15]

B-vitamins, including methylfolate and B12, do not interact pharmacokinetically with trazodone. MTHFR-variant patients are sometimes given L-methylfolate as an antidepressant adjunct, and no interaction signal exists for trazodone specifically.

Trazodone for Sleep: The Off-Label Evidence Base

Trazodone is the most commonly prescribed off-label sleep agent in the United States, yet its RCT evidence base for insomnia is thin compared to its depression evidence. Mendelson's 2005 review in the Journal of Clinical Psychiatry (N= six placebo-controlled studies reviewed) concluded that trazodone produces statistically significant improvements in sleep latency, sleep efficiency, and wake-after-sleep-onset at doses of 50 to 150 mg, but that most trials lasted only one to two weeks. [16] Long-term insomnia data beyond three months remain sparse.

The practical implication for food and supplement interactions: patients using trazodone for insomnia often self-add melatonin, valerian, magnesium, CBD, and alcohol in a trial-and-error search for sleep. That polypharmacy creates a real-world interaction burden that single-agent trials never capture. A structured review of every OTC agent and supplement at each clinical visit is the standard of care, not an optional courtesy.

CBD and Cannabis: An Emerging Interaction

Cannabidiol (CBD) inhibits CYP3A4 and CYP2C19 at concentrations achieved with doses of 300 mg or more per day. [17] At lower doses (10 to 50 mg), the CYP3A4 inhibition is modest but not negligible for a narrow-therapeutic-index drug. Trazodone is not classified as narrow therapeutic index, but it does have a concentration-dependent QT-interval effect. Elevated trazodone levels from CYP3A4 inhibition by CBD could worsen QT prolongation in susceptible patients.

THC (delta-9-tetrahydrocannabinol) adds CNS depression independently and may worsen trazodone-related orthostatic hypotension through its own CB1-mediated cardiovascular effects.

Patients using cannabis products medicinally or recreationally should inform their prescriber. The interaction is manageable with dose awareness, not an absolute contraindication, but it requires acknowledgment.

Practical Dosing and Timing Guidance

The following framework reflects synthesized guideline and pharmacokinetic evidence:

| Situation | Recommendation | |---|---| | Nausea on empty stomach | Take with a small, non-grapefruit snack | | Grapefruit juice in diet | Eliminate entirely while on trazodone | | Alcohol use | Avoid; even 1 to 2 drinks can cause falls in older patients | | St. John's Wort | Discontinue before starting trazodone | | 5-HTP or L-tryptophan | Discontinue before starting; monitor if continued | | Melatonin 0.5 to 1 mg | Generally acceptable; confirm no excess sedation | | Melatonin >5 mg | Use caution; may stack sedation meaningfully | | Valerian 300 to 600 mg | Discuss timing; morning grogginess is the main risk | | CBD >300 mg/day | Flag to prescriber; CYP3A4 inhibition may raise trazodone levels | | Magnesium, omega-3, B-vitamins | Generally compatible; no dose adjustment needed |

When to Contact Your Prescriber Immediately

Certain combinations warrant same-day or emergency contact:

• Any symptoms of serotonin syndrome (agitation, fever, muscle rigidity, rapid heart rate) after starting or changing a supplement
• Fainting or near-fainting after taking trazodone with alcohol or kava
• Prolonged or severe morning sedation that impairs driving or work
• Heart palpitations or chest discomfort (possible QT-interval concern)

The Endocrine Society's guidance on managing polypharmacy in hormone-therapy patients notes that many patients are unaware that OTC supplements carry drug-interaction risks comparable to prescription agents. [18] That gap in patient awareness is where prescriber counseling makes the most practical difference.